Klotho Neurosciences Stock Market Value
| KLTO Stock | 0.28 0.01 3.45% |
| Symbol | Klotho |
Will Stock sector continue expanding? Could Klotho diversify its offerings? Factors like these will boost the valuation of Klotho Neurosciences. Expected growth trajectory for Klotho significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Klotho Neurosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Klotho Neurosciences is measured differently than its book value, which is the value of Klotho that is recorded on the company's balance sheet. Investors also form their own opinion of Klotho Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Klotho Neurosciences' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Klotho Neurosciences' market value can be influenced by many factors that don't directly affect Klotho Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Klotho Neurosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Klotho Neurosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Klotho Neurosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Klotho Neurosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Klotho Neurosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Klotho Neurosciences.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Klotho Neurosciences on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Klotho Neurosciences or generate 0.0% return on investment in Klotho Neurosciences over 90 days. Klotho Neurosciences is related to or competes with Cadrenal Therapeutics, Rallybio Corp, Exicure, Minerva Neurosciences, IBio Common, Neurosense Therapeutics, and TAO Synergies. More
Klotho Neurosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Klotho Neurosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Klotho Neurosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 28.13 | |||
| Value At Risk | (8.57) | |||
| Potential Upside | 10.34 |
Klotho Neurosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Klotho Neurosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Klotho Neurosciences' standard deviation. In reality, there are many statistical measures that can use Klotho Neurosciences historical prices to predict the future Klotho Neurosciences' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.04) | |||
| Total Risk Alpha | (1.30) | |||
| Treynor Ratio | (0.26) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Klotho Neurosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Klotho Neurosciences January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.25) | |||
| Mean Deviation | 4.68 | |||
| Coefficient Of Variation | (699.93) | |||
| Standard Deviation | 6.05 | |||
| Variance | 36.57 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (1.04) | |||
| Total Risk Alpha | (1.30) | |||
| Treynor Ratio | (0.26) | |||
| Maximum Drawdown | 28.13 | |||
| Value At Risk | (8.57) | |||
| Potential Upside | 10.34 | |||
| Skewness | 0.7941 | |||
| Kurtosis | 0.7052 |
Klotho Neurosciences Backtested Returns
Klotho Neurosciences has Sharpe Ratio of -0.14, which conveys that the firm had a -0.14 % return per unit of risk over the last 3 months. Klotho Neurosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Klotho Neurosciences' Risk Adjusted Performance of (0.09), mean deviation of 4.68, and Standard Deviation of 6.05 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 3.31, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Klotho Neurosciences will likely underperform. At this point, Klotho Neurosciences has a negative expected return of -0.86%. Please make sure to verify Klotho Neurosciences' total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Klotho Neurosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.66 |
Good predictability
Klotho Neurosciences has good predictability. Overlapping area represents the amount of predictability between Klotho Neurosciences time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Klotho Neurosciences price movement. The serial correlation of 0.66 indicates that around 66.0% of current Klotho Neurosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.66 | |
| Spearman Rank Test | 0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Pair Trading with Klotho Neurosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Klotho Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Klotho Neurosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Klotho Stock
| 0.78 | BA | Boeing | PairCorr |
| 0.72 | ABEV | Ambev SA ADR Aggressive Push | PairCorr |
| 0.68 | AA | Alcoa Corp | PairCorr |
| 0.63 | F | Ford Motor Earnings Call This Week | PairCorr |
| 0.55 | WMT | Walmart Common Stock | PairCorr |
The ability to find closely correlated positions to Klotho Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Klotho Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Klotho Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Klotho Neurosciences to buy it.
The correlation of Klotho Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Klotho Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Klotho Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Klotho Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Klotho Neurosciences Correlation, Klotho Neurosciences Volatility and Klotho Neurosciences Performance module to complement your research on Klotho Neurosciences. To learn how to invest in Klotho Stock, please use our How to Invest in Klotho Neurosciences guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Klotho Neurosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.